|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4 Suppl 3
|
|
pubmed:dateCreated |
1977-1-29
|
|
pubmed:abstractText |
1 The haemodynamic effects of labetalol have been studied in 11 hypertensive patients after 1 month of oral administration at a fixed dose of 800 mg/d. 2 Heart rate blood pressure and cardiac output were measured at rest and at two levels of exercise. 3 Labetalol significantly reduced heart rate and blood pressure at rest and after exercise but cardiac output remained unchanged. 4 The results suggest that labetalol is an effective anti-hypertensive agent acting by competitive adrenoreceptor blockade.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Aug
|
|
pubmed:issn |
0306-5251
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
3
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
733-6
|
|
pubmed:dateRevised |
2009-10-27
|
|
pubmed:meshHeading |
pubmed-meshheading:791328-Administration, Oral,
pubmed-meshheading:791328-Adult,
pubmed-meshheading:791328-Blood Pressure,
pubmed-meshheading:791328-Cardiac Output,
pubmed-meshheading:791328-Clinical Trials as Topic,
pubmed-meshheading:791328-Drug Administration Schedule,
pubmed-meshheading:791328-Ethanolamines,
pubmed-meshheading:791328-Female,
pubmed-meshheading:791328-Heart Rate,
pubmed-meshheading:791328-Hemodynamics,
pubmed-meshheading:791328-Humans,
pubmed-meshheading:791328-Hypertension,
pubmed-meshheading:791328-Labetalol,
pubmed-meshheading:791328-Male,
pubmed-meshheading:791328-Middle Aged,
pubmed-meshheading:791328-Vascular Resistance
|
|
pubmed:year |
1976
|
|
pubmed:articleTitle |
Haemodynamic effects of long-term oral labetalol.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial
|
